Is DHEA-S the primary adrenal precursor that sustains peripheral androgen production in women after menopause?

Dehydroepiandrosterone sulfate (DHEA-S) serves as the primary reservoir for androgen production in women, functioning as a stable, water-soluble precursor that is converted into active hormones within peripheral tissues. While DHEA-S itself has minimal direct androgenic activity, its high circulating concentration provides the substrate necessary for maintaining hormonal balance, particularly as ovarian function declines.

Clinical evidence and peripheral production

In women, the adrenal glands are the nearly exclusive source of DHEA-S. Evidence from tracer studies indicates that adrenal-derived precursors account for 40% to 60% of total circulating testosterone in premenopausal women.

• The SWAN Study: Longitudinal data from the Study of Women's Health Across the Nation (SWAN) demonstrates that while ovarian estrogen production drops precipitously during the menopausal transition, DHEA-S levels remain a critical foundation for androgenic activity.
• Postmenopausal Shift: After menopause, the contribution of adrenal precursors increases significantly. Research suggests that nearly 100% of active estrogens and the vast majority of androgens in postmenopausal women are synthesized locally in peripheral tissues from adrenal DHEA and DHEA-S.

Mechanistic pathways of conversion

The conversion of DHEA-S into potent androgens occurs through a localized process known as "intracrinology." This allows tissues to regulate their own hormonal environment without releasing high levels of active androgens back into systemic circulation.

• Enzymatic Cascade: DHEA-S is first transported into cells (via OATP transporters) and converted to DHEA by steroid sulfatase (STS).
• Androgen Synthesis: DHEA is transformed into androstenedione by 3β-hydroxysteroid dehydrogenase (3β-HSD). Further conversion to testosterone is catalyzed by 17β-HSD (specifically AKR1C3), and finally to dihydrotestosterone (DHT) via 5α-reductase.
• 11-Oxygenated Androgens: Recent evidence highlights that 11-oxygenated adrenal androgens (such as 11-ketotestosterone) do not decline significantly after menopause, further supporting the adrenal gland's role in maintaining androgenic bioactivity in older women.

Bottom line

DHEA-S is a vital adrenal precursor that sustains peripheral androgen levels through localized enzymatic conversion. Its role is especially critical after menopause, when it becomes the primary source for sex steroid production in the absence of cyclic ovarian function.